Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New injection plus radiation aims to fight cervical cancer

NCT ID NCT05570422

First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 26 times

Summary

This study tests a new drug called KRC-01, injected directly into the tumor, combined with standard radiation therapy for people with locally advanced cervical cancer. The trial has two parts: first, a small group to check safety and find the best dose; second, a larger group to see if the combination helps control the cancer better than radiation alone. About 70 participants will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site 2

    NOT_YET_RECRUITING

    Chandigarh, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Site 3

    NOT_YET_RECRUITING

    Manchester, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Site 4

    RECRUITING

    Chiang Mai, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Site 5

    RECRUITING

    Bangkok, Bangkok, 10700, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.